Addition of dupilumab for patients with aspirin-exacerbated respiratory disease who have poor response to aspirin therapy after desensitization is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: U19 AI095219
National Institutes of Health
Grant: K23AI139352
National Institutes of Health
Grant: K24AI180296
National Institutes of Health
Grant: R21AI182809
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords